COMPANY PROFILE

ResMed

A global leader in digital health and connected medical devices, plus software solutions that support out-of-hospital care providers

San Diego, United StatesFounded 1981Health Tech & Medtech

Valuation $33B Market cap · 2026

Revenue $5.65B Latest reported FY

EBITDA $2.17B Latest reported FY

About ResMed

ResMed (NYSE: RMD, ASX: RMD) develops cloud-connected medical devices and software platforms aimed at treating and managing sleep apnea, COPD, and other chronic diseases. The company serves patients, healthcare professionals, and caregivers, providing solutions that enable better care and improve quality of life. Operating in over 120 countries, ResMed's business model focuses on selling medical devices and software subscriptions, generating revenue through product sales and recurring service fees. By reducing hospital visits and lowering healthcare costs, ResMed addresses the needs of both consumers and healthcare systems.

MoreLess Source: Dealroom company data

At a glance

Status: Listed
Founded: 1981
Headquarters: San Diego, United States
Listing: IPO 1995
Employees: 9,178
Open positions: 137
Dealroom signal: 85.5/100
Industry: Health, Wellness Beauty
Sub-industry: Health Platform
Sector: Health Tech & Medtech, Intellectual Property, Testing, Biotechnology, Non-Invasive medical devices and treatments, Spinout, medical testing
Business model: Manufacturing, Marketplace & ecommerce
Client focus: b2c
Investment activity: 22 companies, latest May 2026
Capital deployed: $99M
Preferred round: ACQUISITION
Links: Website LinkedIn X

Knowledge graph

Founder mafia, market maps, research and news connected to this company by Dealroom

Funding history

4 recorded events

Company financing events and reported valuations.

Deal type	Date	Amount	Valuation	Investors	Source
POST IPO EQUITY✓Other financing	Jun 2026	$0	—	Manulife Financial	↗
POST IPO DEBT✓Debt	Jul 2019	$500M	—	Undisclosed	↗

Showing the latest 2 of 4 recorded eventsBook a demo for the full funding history →

Financials

Revenue, earnings and profit over time

Revenue, earnings and other financial measures where available. Years marked “E” are estimates.

Year	Revenue	Growth	EBITDA	Margin	Profit	Margin	R&D
2026	$5.7B	+9.9%	$2.2B	38.5%	$1.5B	26.9%	$378M
2025	$5.1B	+9.8%	$1.9B	37.4%	$1.4B	27.2%	$331M
2024	$4.7B	+10.9%	$1.6B	34%	$1B	21.8%	$308M
2023	$4.2B	+18%	$1.3B	31.7%			$288M
2022	$3.6B	+11.9%	$1.2B	33.4%
2021	$3.2B	+8.1%	$1.1B	34.8%
2020	$3B	—	$990M	33.5%

Company filings, research estimates and Dealroom dataBook a demo for the full financial model →

Growth signals

ResMed website traffic

Latest recorded traffic for ResMed is 3.4M monthly website visits, down 2.9% over the last three months. ResMed's team grew 31.4% over the past year.

Latest monthly visits3.4M 3-month web change-2.9% 1-year team growth+31.4%

Monthly website visitsApr 2016–Mar 2021

Explore monthly traffic historyTrack growth over time and compare with peersBook a demo

Summary metrics are public; monthly history is available with a demoCompare with peers →

Open positions

Openings linked to this company in Dealroom

Senior UX DesignerSan Diego, California, United States, Northern America, Americas · Design · Oct 1, 2026 Senior Systems Engineer (Operational Technology)Singapore, Singapore, South-eastern Asia, Asia · Backend Development · Oct 1, 2026 UX/UI DesignerSydney, New South Wales, Australia, Australia and New Zealand, Oceania · Design · Sep 30, 2026 Territory Manager (Jacksonville, Florida)Jacksonville, Florida, United States, Northern America, Americas · Other · Sep 30, 2026 Lead User Researcher - Hardware ResearchSydney, New South Wales, Australia, Australia and New Zealand, Oceania · Backend Development · Sep 30, 2026 Engineering Excellence LeadSingapore, Singapore, South-eastern Asia, Asia · Other · Sep 30, 2026 TA Lead, Product & Technology - AmericasSan Diego, California, United States, Northern America, Americas · Business Development · Sep 29, 2026 Sachbearbeiter Privatpatientenservice (m/w/d) - befristetMunich, Germany, Western Europe, Europe · Other · Sep 29, 2026

8 distinct openings shownExplore hiring signals →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Company	Headquarters	Status	Employees	Total funding	Valuation
MImiDiagnosticsSilicon chip diagnostics for rapid, lab-quality results	Leuven, Belgium	Operational	57	$103M	$132M
RERepairogenRepairogen employs proprietary DNA-repair technologies to create advanced, scientifically-proven skincare products	New York City, United States	Operational
SPSPARKITEAddiction treatment facilities and their clients with addiction support in the pocket	New York City, United States	Operational
ANANTERIOSInnovative biopharmaceutical solutions tackling the toughest health challenges with a focus on impactful treatments	New York City, United States	Acquired
VIVitaScanA point-of-care diagnostics company that develops simple, scalable, and quantitative tests to solve health problems by identifying nutritional deficiencies	Ithaca, United States	Operational
EMEmboMedicsEmboMedics, Inc develops and commercializes resorbable and drug loaded embolization devices for the treatment of multiple indicationsThe	Golden Valley, United States	Operational
IOioveraMyoScience develops and commercializes technology-driven dermatological products	Fremont, United States	Acquired
NENeuroQuestAI-driven solutions for optimizing home maintenance and property management	Modi'in-Maccabim-Re'ut, Israel	Operational